drugset / Trial / NCT00927979

Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy

NCT00927979

Phase 3 Completed 40 enrolled Carmel Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.

Timeline

Start
2009-06
Primary completion
2010-07
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 1 % Other
Subject Ropivacaine Other / unclassified 10 ml Other

Indications

No indication recorded.